<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anti-oxidative enzymes protect living bodies from various oxidative stresses </plain></SENT>
<SENT sid="1" pm="."><plain>In the systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, autoantibodies to oxidized molecules and to anti-oxidative enzymes have been reported </plain></SENT>
<SENT sid="2" pm="."><plain>To promote understanding of the relationships between <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> and <z:mp ids='MP_0003674'>oxidative stress</z:mp>, we here investigate whether <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> to the anti-oxidative peroxiredoxin (Prxs) enzymes exists in patients with systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Specifically, we detected autoantibodies to recombinant Prx I and Prx IV respectively by ELISA and western blotting </plain></SENT>
<SENT sid="4" pm="."><plain>Next, clinical parameters were compared between the anti-Prx I or IV-positive and-negative patients </plain></SENT>
<SENT sid="5" pm="."><plain>We found that 33% of the 92 patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> tested possessed autoantibodies to Prx I (57% in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), 19% in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA), 5% in <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et disease, and 46% in primary <z:hpo ids='HP_0002633'>vasculitis</z:hpo> syndrome) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, autoantibodies to Prx IV were detected in only 17% of the same patients </plain></SENT>
<SENT sid="7" pm="."><plain>No significant correlation was found between occurrence of the two autoantibodies </plain></SENT>
<SENT sid="8" pm="."><plain>Clinically, possession of anti-Prx I autoantibodies correlated with lower serum levels of CH50, C3, and C4 </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, our data demonstrate the existence of autoantibodies to Prxs for the first time </plain></SENT>
<SENT sid="10" pm="."><plain>The autoantibodies to Prx I may be involved in the pathophysiology of systemic <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> such as SLE and <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
</text></document>